1	Bcl-2	bcl-2	_	_	_	_	_	_	_
2	protein	protein	_	_	_	_	_	_	_
3	inhibits	inhibit	_	_	_	_	_	_	_
4	bufalin-induced	bufalin-induced	_	_	_	_	_	_	_
5	apoptosis	apoptosis	_	_	_	_	_	_	_
6	through	through	_	_	_	_	_	_	_
7	inhibition	inhibition	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	mitogen-activated	mitogen-activated	_	_	_	_	_	_	_
10	protein	protein	_	_	_	_	_	_	_
11	kinase	kinase	_	_	_	_	_	_	_
12	activation	activation	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	human	human	_	_	_	_	_	_	_
15	leukemia	leukemia	_	_	_	_	_	_	_
16	U937	u937	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	a	a	_	_	_	_	_	_	_
3	previous	previous	_	_	_	_	_	_	_
4	study	study	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	we	we	_	_	_	_	_	_	_
7	demonstrated	demonstrate	_	_	_	_	_	_	_
8	that	that	_	_	_	_	_	_	_
9	bufalin	bufalin	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	which	which	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	an	an	_	_	_	_	_	_	_
14	active	active	_	_	_	_	_	_	_
15	principle	principle	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	Chinese	chinese	_	_	_	_	_	_	_
18	medicine	medicine	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	chanâ€™su	chan'su	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	caused	cause	_	_	_	_	_	_	_
23	apoptosis	apoptosis	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	human	human	_	_	_	_	_	_	_
26	leukemia	leukemia	_	_	_	_	_	_	_
27	U937	u937	_	_	_	_	_	_	_
28	cells	cell	_	_	_	_	_	_	_
29	by	by	_	_	_	_	_	_	_
30	anomalous	anomalous	_	_	_	_	_	_	_
31	activation	activation	_	_	_	_	_	_	_
32	of	of	_	_	_	_	_	_	_
33	mitogen-activated	mitogen-activated	_	_	_	_	_	_	_
34	protein	protein	_	_	_	_	_	_	_
35	kinase	kinase	_	_	_	_	_	_	_
36	(	(	_	_	_	_	_	_	_
37	MAPK	MAPK	_	_	_	_	_	_	_
38	)	)	_	_	_	_	_	_	_
39	via	via	_	_	_	_	_	_	_
40	the	the	_	_	_	_	_	_	_
41	signaling	signaling	_	_	_	_	_	_	_
42	pathway	pathway	_	_	_	_	_	_	_
43	of	of	_	_	_	_	_	_	_
44	Ras	Ras	_	_	_	_	_	_	_
45	,	,	_	_	_	_	_	_	_
46	Raf-1	Raf-1	_	_	_	_	_	_	_
47	,	,	_	_	_	_	_	_	_
48	and	and	_	_	_	_	_	_	_
49	MAPK	MAPK	_	_	_	_	_	_	_
50	kinase-1	kinase-1	_	_	_	_	_	_	_
51	.	.	_	_	_	_	_	_	_

1	Here	here	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	we	we	_	_	_	_	_	_	_
4	report	report	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	effect	effect	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	overexpression	overexpression	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	bcl-2	bcl-2	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	U937	u937	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	on	on	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	signaling	signaling	_	_	_	_	_	_	_
17	pathway	pathway	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	apoptosis	apoptosis	_	_	_	_	_	_	_
20	that	that	_	_	_	_	_	_	_
21	is	be	_	_	_	_	_	_	_
22	induced	induce	_	_	_	_	_	_	_
23	by	by	_	_	_	_	_	_	_
24	bufalin	bufalin	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	indicated	indicate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	apoptosis	apoptosis	_	_	_	_	_	_	_
7	induced	induce	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	bufalin	bufalin	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	U937	u937	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	was	be	_	_	_	_	_	_	_
14	significantly	significantly	_	_	_	_	_	_	_
15	inhibited	inhibit	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	overexpression	overexpression	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	Bcl-2	bcl-2	_	_	_	_	_	_	_
21	protein	protein	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	No	no	_	_	_	_	_	_	_
2	significant	significant	_	_	_	_	_	_	_
3	difference	difference	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	detected	detect	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	activation	activation	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	MAPK	MAPK	_	_	_	_	_	_	_
11	kinase-1	kinase-1	_	_	_	_	_	_	_
12	that	that	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	induced	induce	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	bufalin	bufalin	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	wild-type	wild-type	_	_	_	_	_	_	_
19	or	or	_	_	_	_	_	_	_
20	Bcl-2-overexpressed	bcl-2-overexpressed	_	_	_	_	_	_	_
21	U937	u937	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	;	;	_	_	_	_	_	_	_
24	however	however	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	activation	activation	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	MAPK	MAPK	_	_	_	_	_	_	_
30	by	by	_	_	_	_	_	_	_
31	bufalin	bufalin	_	_	_	_	_	_	_
32	was	be	_	_	_	_	_	_	_
33	significantly	significantly	_	_	_	_	_	_	_
34	attenuated	attenuate	_	_	_	_	_	_	_
35	in	in	_	_	_	_	_	_	_
36	the	the	_	_	_	_	_	_	_
37	cells	cell	_	_	_	_	_	_	_
38	overexpressing	overexpresse	_	_	_	_	_	_	_
39	Bcl-2	bcl-2	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	Bufalin	Bufalin	_	_	_	_	_	_	_
2	treatment	treatment	_	_	_	_	_	_	_
3	activated	activate	_	_	_	_	_	_	_
4	activator	activator	_	_	_	_	_	_	_
5	protein-1	protein-1	_	_	_	_	_	_	_
6	transcriptional	transcriptional	_	_	_	_	_	_	_
7	activity	activity	_	_	_	_	_	_	_
8	;	;	_	_	_	_	_	_	_
9	however	however	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	this	this	_	_	_	_	_	_	_
12	activation	activation	_	_	_	_	_	_	_
13	was	be	_	_	_	_	_	_	_
14	decreased	decrease	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	40	40	_	_	_	_	_	_	_
17	%	%	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	bcl-2-overexpressed	bcl-2-overexpressed	_	_	_	_	_	_	_
20	U937	u937	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	indicate	indicate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	Bcl-2	bcl-2	_	_	_	_	_	_	_
6	acts	act	_	_	_	_	_	_	_
7	downstream	downstream	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	MAPK	MAPK	_	_	_	_	_	_	_
10	kinase-1	kinase-1	_	_	_	_	_	_	_
11	but	but	_	_	_	_	_	_	_
12	upstream	upstream	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	MAPK	MAPK	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	suggest	suggest	_	_	_	_	_	_	_
17	that	that	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	signaling	signaling	_	_	_	_	_	_	_
22	pathway	pathway	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	apoptotic	apoptotic	_	_	_	_	_	_	_
26	process	process	_	_	_	_	_	_	_
27	induced	induce	_	_	_	_	_	_	_
28	by	by	_	_	_	_	_	_	_
29	bufalin	bufalin	_	_	_	_	_	_	_
30	,	,	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	transcriptional	transcriptional	_	_	_	_	_	_	_
33	activity	activity	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	activator	activator	_	_	_	_	_	_	_
36	protein-1	protein-1	_	_	_	_	_	_	_
37	may	may	_	_	_	_	_	_	_
38	be	be	_	_	_	_	_	_	_
39	down-regulated	down-regulate	_	_	_	_	_	_	_
40	through	through	_	_	_	_	_	_	_
41	the	the	_	_	_	_	_	_	_
42	inhibition	inhibition	_	_	_	_	_	_	_
43	of	of	_	_	_	_	_	_	_
44	MAPK	MAPK	_	_	_	_	_	_	_
45	activity	activity	_	_	_	_	_	_	_
46	by	by	_	_	_	_	_	_	_
47	Bcl-2	bcl-2	_	_	_	_	_	_	_
48	.	.	_	_	_	_	_	_	_

